24345162|t|Reduction in DHA transport to the brain of mice expressing human APOE4 compared to APOE2.
24345162|a|Benefits on cognition from docosahexaenoic acid (DHA, 22 : 6 n-3) intake are absent in humans carrying apolipoprotein E epsilon4 allele (APOE4), the most important genetic risk factor for Alzheimer's disease (AD). To test the hypothesis that carrying APOE4 impairs DHA distribution, we evaluated plasma and brain fatty acid profiles and uptake of [(14) C]-DHA using in situ cerebral perfusion through the blood-brain barrier in 4- and 13-month-old male and female APOE-targeted replacement mice (APOE2, APOE3, and APOE4), fed with a DHA-depleted diet. Cortical and plasma DHA were 9% lower and 34% higher in APOE4 compared to APOE2 mice, respectively. Brain uptake of [(14) C]-DHA was 24% lower in APOE4 versus APOE2 mice. A significant relationship was established between DHA and apoE concentrations in the cortex of mice (r(2) = 0.21) and AD patients (r(2) = 0.32). Altogether, our results suggest that lower brain uptake of DHA in APOE4 than in APOE2 mice may limit the accumulation of DHA in cerebral tissues. These data provide a mechanistic explanation for the lack of benefit of DHA in APOE4 carriers on cognitive function and the risk of AD. Using human APOE2, 3, and 4 isoform-specific transgenic mice, we found a lower brain uptake of docosahexaenoic acid (DHA) in APOE4 than in APOE2 mice that may limit the biodistribution of DHA in cerebral tissues. These data provide a mechanistic explanation for the lack of benefit of DHA in APOE4 carriers on cognitive function and the risk of Alzheimer's disease (AD).
24345162	13	16	DHA	Chemical	MESH:D004281
24345162	43	47	mice	Species	10090
24345162	59	64	human	Species	9606
24345162	65	70	APOE4	Gene	348
24345162	83	88	APOE2	Gene	348
24345162	117	137	docosahexaenoic acid	Chemical	MESH:D004281
24345162	139	142	DHA	Chemical	MESH:D004281
24345162	144	154	22 : 6 n-3	Chemical	-
24345162	177	183	humans	Species	9606
24345162	193	209	apolipoprotein E	Gene	348
24345162	227	232	APOE4	Gene	348
24345162	278	297	Alzheimer's disease	Disease	MESH:D000544
24345162	299	301	AD	Disease	MESH:D000544
24345162	341	346	APOE4	Gene	348
24345162	355	358	DHA	Chemical	MESH:D004281
24345162	403	413	fatty acid	Chemical	MESH:D005227
24345162	437	449	[(14) C]-DHA	Chemical	-
24345162	580	584	mice	Species	10090
24345162	586	591	APOE2	Gene	348
24345162	604	609	APOE4	Gene	348
24345162	623	626	DHA	Chemical	MESH:D004281
24345162	662	665	DHA	Chemical	MESH:D004281
24345162	698	703	APOE4	Gene	348
24345162	716	721	APOE2	Gene	348
24345162	722	726	mice	Species	10090
24345162	758	770	[(14) C]-DHA	Chemical	-
24345162	788	793	APOE4	Gene	348
24345162	801	806	APOE2	Gene	348
24345162	807	811	mice	Species	10090
24345162	864	867	DHA	Chemical	MESH:D004281
24345162	909	913	mice	Species	10090
24345162	932	934	AD	Disease	MESH:D000544
24345162	935	943	patients	Species	9606
24345162	1018	1021	DHA	Chemical	MESH:D004281
24345162	1025	1030	APOE4	Gene	348
24345162	1039	1044	APOE2	Gene	348
24345162	1045	1049	mice	Species	10090
24345162	1080	1083	DHA	Chemical	MESH:D004281
24345162	1177	1180	DHA	Chemical	MESH:D004281
24345162	1184	1189	APOE4	Gene	348
24345162	1237	1239	AD	Disease	MESH:D000544
24345162	1247	1252	human	Species	9606
24345162	1253	1268	APOE2, 3, and 4	Gene	348
24345162	1297	1301	mice	Species	10090
24345162	1336	1356	docosahexaenoic acid	Chemical	MESH:D004281
24345162	1358	1361	DHA	Chemical	MESH:D004281
24345162	1366	1371	APOE4	Gene	348
24345162	1380	1385	APOE2	Gene	348
24345162	1386	1390	mice	Species	10090
24345162	1429	1432	DHA	Chemical	MESH:D004281
24345162	1526	1529	DHA	Chemical	MESH:D004281
24345162	1533	1538	APOE4	Gene	348
24345162	1586	1605	Alzheimer's disease	Disease	MESH:D000544
24345162	1607	1609	AD	Disease	MESH:D000544
24345162	Negative_Correlation	MESH:D004281	MESH:D000544
24345162	Association	MESH:D004281	348
24345162	Association	MESH:D000544	348

